ER
DXCM icon

Enlightenment Research’s DexCom DXCM Stock Holding History

Enlightenment Research’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-4,000
Closed -$537K – 161
2021
Q4 		$537K Buy
+4,000
New +$575K 0.76% 39
2020
Q3 		– Sell
-8,800
Closed -$892K – 88
2020
Q2 		$892K Buy
+8,800
New +$787K 2.13% 10
2019
Q2 		– Sell
-11,200
Closed -$333K – 277
2019
Q1 		$333K Buy
+11,200
New +$394K 0.65% 51

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Enlightenment Research's DXCM Position: Q1 2022 in Review

Enlightenment Research sold out of DexCom (DXCM) in Q1 2022, closing a stake of 4,000 shares — an estimated $537K sold.

Enlightenment Research first reported a position in DXCM in Q1 2019 and held it in 3 quarters. The position peaked at $892K in Q2 2020. 862 funds tracked by Wall St. Rank hold DXCM as of Q1 2022.

  • Enlightenment Research reported no remaining DexCom position as of Q1 2022 after selling out during the quarter.
  • Enlightenment Research sold 4,000 DexCom shares in Q1 2022, an estimated $537K.
  • Enlightenment Research first reported a position in DexCom in Q1 2019 and held it in 3 quarters.
  • Enlightenment Research's DexCom position peaked at $892K in Q2 2020.
  • 862 funds tracked by Wall St. Rank held DexCom as of Q1 2022.

Based on Enlightenment Research's 13F filing for Q1 2022, filed 13 May 2022.